Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Anna Stoelinga; Maaike Biewenga; Joost P.H. Drenth; Xavier Verhelst; Adriaan J. P. van der Meer; Ynto S. de Boer; Gerd Bouma; Elsemieke S de Vries; Robert C. Verdonk; Aad P van der Berg; Johannes T. Brouwer; Thomas Vanwolleghem; Willem J. Lammers; Ulrich Beuers; Arantza Fariña Sarasqueta; Joanne Verheij; Tania Roskams; Stijn Crobach; Maarten E. Tushuizen; Bart van Hoek

doi:10.1016/j.jhepr.2024.101088

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) can co-exist in AIH-PBC, requiring combined treatment with immunosuppression and ursodeoxycholic acid (UDCA). The Paris criteria are commonly used to identify these patients; however, the optimal diagnostic criteria are unknown. We aimed to evaluate the use and clinical relevance of both Paris and Zhang criteria.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Stoelinga et al. (2024) studied this question.

synapsesocial.com/papers/68e64b22b6db6435875db623 https://doi.org/10.1016/j.jhepr.2024.101088

View Full Paper

Ask AI

Bookmark

Share

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Ask about this paper

Abstract

Discussion

Cite This Study

Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading